Distribuzione geografica
Continente #
EU - Europa 1377
NA - Nord America 1001
AS - Asia 198
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2583
Nazione #
US - Stati Uniti d'America 1000
IE - Irlanda 553
SE - Svezia 286
IT - Italia 271
CN - Cina 176
PL - Polonia 119
FR - Francia 48
DE - Germania 27
BE - Belgio 22
GB - Regno Unito 16
FI - Finlandia 14
VN - Vietnam 9
IN - India 6
NL - Olanda 5
RU - Federazione Russa 5
HK - Hong Kong 4
UA - Ucraina 4
CL - Cile 3
EU - Europa 3
AT - Austria 2
BR - Brasile 1
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
JP - Giappone 1
RO - Romania 1
RS - Serbia 1
SG - Singapore 1
Totale 2583
Città #
Dublin 553
Chandler 321
Nyköping 219
Warsaw 118
Messina 96
Princeton 74
Beijing 69
Medford 65
Ann Arbor 51
Des Moines 47
Jacksonville 37
Wilmington 30
Bremen 24
Dearborn 24
Cambridge 19
Brussels 18
Jinan 14
Redwood City 14
Duncan 12
Falls Church 12
Boardman 10
Rome 10
Zhengzhou 10
Shenyang 9
Dong Ket 8
Houston 8
Ningbo 8
Changsha 7
Haikou 7
Livorno 7
Nanjing 7
San Mateo 7
Hebei 6
Tianjin 6
Woodbridge 6
Collegeville 5
Hangzhou 5
North Brunswick 5
Padova 5
Piazza Armerina 5
Taizhou 5
Aci Sant'antonio 4
Ashburn 4
Chicago 4
Fuzhou 4
London 4
Waanrode 4
Catania 3
Como 3
Kemerovo 3
Lancaster 3
Nanchang 3
Sortino 3
Taiyuan 3
Fiumefreddo Di Sicilia 2
Gravina di Catania 2
Guangzhou 2
Inverigo 2
Lanzhou 2
Lucca 2
Norwalk 2
Palermo 2
Seattle 2
Torino 2
Vienna 2
Woodbine 2
Albuquerque 1
Amsterdam 1
Avezzano 1
Belgrade 1
Bologna 1
Bracknell 1
Bury 1
Clarks Summit 1
Codigoro 1
Fairfield 1
Hamburg 1
Hanoi 1
Helsinki 1
Hunedoara 1
Jakarta 1
Jeffries 1
Kiev 1
Kraków 1
La Canada Flintridge 1
Lago 1
Leninsk-kuznetskiy 1
Londrina 1
Milan 1
Modena 1
Montréal 1
New Delhi 1
New York 1
Peckville 1
Piraeus 1
Puxian 1
Rivarolo Canavese 1
Salou 1
San Fermo della Battaglia 1
Singapore 1
Totale 2066
Nome #
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 125
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 113
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 107
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 102
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 87
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 67
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 62
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 61
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 61
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 55
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 55
A Nouvel serum MicroRNA signature to screen ATTR 54
null 54
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 49
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 49
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 48
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 47
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 46
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 46
Considerable post-partum worsening in a patient with CMT2E 45
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 44
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 41
The THAOS: record of patients from our site. 40
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 40
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 40
Early detection of cardiac amyloid deposition in patients with transthyretin-related familial amyloid polyneuropathy by 99mTc-diphosphonate scintigraphy 38
Use of the International Classification of Functioning, Disability and Health Generic-30 Set for the characterization of outpatients: Italian Society of physical and rehabilitative medicine residents section project 38
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 37
Early detection of cardiac amyloid deposition in subjects with transthyretin gene mutation by 99mTc-disphosphonate scintigraphy 36
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 36
"It is not what it seems." Ultrasound findings in a case of unusual iatrogenic ulnar nerve damage. 36
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 35
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale 35
A multicentre study on epidemiology and prevention of needle stick injuries among students of nursing schools 32
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 32
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 31
null 30
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 28
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 28
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 27
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 27
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 27
null 26
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 26
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 25
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 25
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 25
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 25
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 23
A Cyst Compressing the Ulnar Nerve Motor Branch: Ultrasonographic Diagnosis of a Tricking Neuropathy. 23
"Seeing Through the Wall": Ultrasound Application for the Diagnosis and Treatment of Abdominal Pain. 23
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 23
TTR-FAP: a single-center experience in Sicily, an Italian endemic area 22
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 21
null 21
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study 21
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 20
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 19
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 19
Impact of environmental factors and physical activity on disability and quality of life in CIDP 19
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area 19
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 19
Shear wave elastography of median nerve at wrist and forearm. Heterogeneity of normative values. 15
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 15
"Who seeks finds, who compares discovers". Usefulness of ultrasound to assess small nerve branches. 15
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 15
Rare among rare: Phenotypes of uncommon CMT genotypes 15
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 14
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 14
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 13
Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in Sicily, an italian endemic area. 12
Ultrasound guidance increases diagnostic yield of needle EMG in plegic muscle. 12
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 10
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 9
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS 8
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 4
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 1
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease 1
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 1
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 1
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 1
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 1
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 1
Totale 2777
Categoria #
all - tutte 6439
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6439

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201815 0000 00 00 00150
2018/201934 5421 91 14 0421
2019/2020375 12225 638 2952 271024060
2020/2021455 21217221 9927 4218 23742116
2021/2022481 1448316 4211 4929 172231199
2022/20231339 1081167876 86115 1961 65216120
Totale 2777